Keywords: s-p, tra, drug, meets, ph, ii, endpoints

S-P's TRA drug meets Ph II endpoints

Article | 02 April 2007

Print This

US drug major Schering-Plough reported positive results from a Phase II trial of its novel oral thrombin receptor antagonist (TRA) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in